CareDx, Inc. Files 8-K on Shareholder Votes and Financials
Ticker: CDNA · Form: 8-K · Filed: Jun 18, 2024 · CIK: 1217234
Sentiment: neutral
Topics: corporate-governance, financial-reporting, filing
Related Tickers: CDNA
TL;DR
CareDx filed an 8-K on June 13th for shareholder votes and financials.
AI Summary
On June 13, 2024, CareDx, Inc. filed an 8-K report detailing the submission of matters to a vote of security holders and financial statements. The filing also includes exhibits related to these matters. The company, formerly known as XDx, Inc. and Expression Diagnostics Inc., is incorporated in Delaware and headquartered in Brisbane, California.
Why It Matters
This filing provides an update on corporate governance and financial reporting for CareDx, Inc., which is important for investors to track the company's operational and financial status.
Risk Assessment
Risk Level: low — This is a routine filing reporting on corporate actions and financial statements, not indicating any immediate operational or financial distress.
Key Numbers
- 001-36536 — SEC File Number (Identifies the company's filing history with the SEC.)
- 94-3316839 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- CareDx, Inc. (company) — Registrant
- June 13, 2024 (date) — Date of earliest event reported
- XDx, Inc. (company) — Former company name
- Expression Diagnostics Inc (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Brisbane, California (location) — Principal executive offices
- 415-287-2300 (phone_number) — Registrant's telephone number
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
What financial statements are included in this filing?
The filing states that 'Financial Statements and Exhibits' are included, but the specific financial statements are not detailed in the provided text.
When was CareDx, Inc. previously known as XDx, Inc.?
The date of the name change from XDx, Inc. to CareDx, Inc. was October 10, 2007.
What is the principal business address of CareDx, Inc.?
The principal executive offices are located at 8000 Marina Blvd, 4th Floor, Brisbane, California 94005.
What is the filing date of this Current Report?
The date of the report, and the earliest event reported, is June 13, 2024.
Filing Stats: 967 words · 4 min read · ~3 pages · Grade level 10.4 · Accepted 2024-06-18 15:56:03
Key Financial Figures
- $0.001 — nge on which registered) Common Stock, $0.001 Par Value CDNA The Nasdaq Stock Market
Filing Documents
- cdna-20240613.htm (8-K) — 59KB
- caredxinc2024equityincenti.htm (EX-10.1) — 202KB
- 0001217234-24-000071.txt ( ) — 429KB
- cdna-20240613.xsd (EX-101.SCH) — 2KB
- cdna-20240613_lab.xml (EX-101.LAB) — 22KB
- cdna-20240613_pre.xml (EX-101.PRE) — 13KB
- cdna-20240613_htm.xml (XML) — 3KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On June 13, 2024, the Company held the Annual Meeting. Of the 52,008,077 shares of the Company's common stock outstanding as of April 18, 2024, the record date for the Annual Meeting, 47,357,347 shares were represented at the Annual Meeting virtually or by proxy, constituting approximately 91.05% of the outstanding shares entitled to vote and constituting a quorum for the transaction of business. At the Annual Meeting, the Company's stockholders considered four proposals, each of which is described in more detail in the Proxy Statement. Set forth below is a brief description of each proposal voted upon at the Annual Meeting and the voting results with respect to each proposal. Proposal No. 1 – To elect three Class I directors to serve until the 2027 annual meeting of stockholders or until their successors are duly elected and qualified . Nominee Votes For Votes Withheld Broker Non-Votes George W. Bickerstaff, III 34,608,883 5,973,871 6,774,593 Christine M. Cournoyer 40,143,926 438,828 6,774,593 Hannah Valantine, M.D. 39,974,626 608,128 6,774,593 As a result, the Company's stockholders voted to elect each of George W. Bickerstaff, III, Christine M. Cournoyer, and Hannah Valantine, M.D. as Class I directors to serve until the Company's 2027 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. Proposal No. 2 – To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2024. Votes For Votes Against Abstentions Broker Non-Votes 47,062,774 165,601 128,972 — As a result, the Company's stockholders voted to ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2024. Proposal No. 3 – To approve, on an advisory basis, the compensation of the Company
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1 CareDx, Inc. 2024 Equity Incentive Plan 104 Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 18, 2024 CAREDX, INC. By: /s/ John W. Hanna John W. Hanna President and Chief Executive Officer